Detalhe da pesquisa
1.
JAK/STAT defects and immune dysregulation, and guiding therapeutic choices.
Immunol Rev
; 322(1): 311-328, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38306168
Mostrar mais
Texto completo
Documentos relacionados
2.
Treatments for COVID-19.
Annu Rev Med
; 75: 145-157, 2024 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37722709
3.
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
N Engl J Med
; 388(21): 1966-1980, 2023 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37224198
4.
Baricitinib and ß-Cell Function in Patients with New-Onset Type 1 Diabetes.
N Engl J Med
; 389(23): 2140-2150, 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38055252
5.
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
N Engl J Med
; 386(18): 1687-1699, 2022 05 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35334197
6.
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
N Engl J Med
; 386(4): 316-326, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35081280
7.
IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition.
Blood
; 142(2): 158-171, 2023 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37023368
8.
Biology and therapeutic targeting of molecular mechanisms in MPNs.
Blood
; 141(16): 1922-1933, 2023 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36534936
9.
Macrophage re-programming by JAK inhibitors relies on MAFB.
Cell Mol Life Sci
; 81(1): 152, 2024 Mar 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38528207
10.
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
J Allergy Clin Immunol
; 153(1): 275-286.e18, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37935260
11.
A panel of janus kinase inhibitors identified with anti-inflammatory effects protect mice from lethal influenza virus infection.
Antimicrob Agents Chemother
; 68(4): e0135023, 2024 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38470034
12.
Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology.
Curr Opin Rheumatol
; 36(2): 113-119, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38126228
13.
Neuropathologic Impacts of JAK Inhibitor Treatment in Aicardi-Goutières Syndrome.
J Clin Immunol
; 44(3): 68, 2024 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38381212
14.
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
Lancet
; 401(10383): 1159-1171, 2023 04 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36871574
15.
Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib.
J Clin Immunol
; 44(4): 85, 2024 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38578354
16.
Rheumatoid arthritis.
Lancet
; 402(10416): 2019-2033, 2023 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38240831
17.
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Lancet
; 401(10373): 269-280, 2023 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36709073
18.
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.
N Engl J Med
; 384(13): 1227-1239, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33789011
19.
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med
; 385(5): 406-415, 2021 07 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34133856
20.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med
; 384(9): 795-807, 2021 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33306283
